Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Background The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) results in significant clinical improvements, compared with placebo. This paper presents the key magnetic resonance imaging (MRI) findings fr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic advances in neurological disorders Jg. 11; S. 1756285617753365
Hauptverfasser:	Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London, England SAGE Publications 01.01.2018 SAGE PUBLICATIONS, INC SAGE Publishing
Schriftenreihe:	Therapeutic Advances in Neurological Disorders
Schlagworte:	Life Sciences Magnetic resonance imaging Multiple sclerosis NMR Nuclear magnetic resonance Original Research relapsing–remitting multiple sclerosis magnetic resonance imaging cladribine extension study relapsing-remitting multiple sclerosis
ISSN:	1756-2864, 1756-2856, 1756-2864
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!